LENSAR, Inc. (LNSR)

Market Cap	73.72M -54.7%
Revenue (ttm)	57.70M +1.1%
Net Income	29.40M
EPS	2.28
Shares Out	12.10M
PE Ratio	2.67
Forward PE	3.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,984
Open	5.95
Previous Close	5.95
Day's Range	5.95 - 6.09
52-Week Range	5.06 - 14.03
Beta	0.84
Analysts	Strong Buy
Price Target	8.50 (+40.5%)
Earnings Date	May 8, 2026

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 150
• Stock Exchange: NASDAQ
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2025, LENSAR's revenue was $58.44 million, an increase of 9.24% compared to the previous year's $53.49 million. Losses were -$34.28 million, 9.16% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for LNSR stock is "Strong Buy." The 12-month stock price target is $8.5, which is an increase of 40.50% from the latest price.

Price Target

$8.5

(40.50% upside)

Analyst Consensus: Strong Buy